← Back to Conditions

Haemolytic disease of foetus OR newborn due to isoimmunisation

disorder
SNOMED 387705004CUI C0014761

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Clinical Trials

1
Total Trials
0
Recruiting
1
With Results

Recent Trials

Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease

NCT00288600Phase 4Completed92 enrolled
View all 1 trials on ClinicalTrials.gov

Related Conditions

Hemolytic disease of the newborn due to non-ABO, non-Rh isoimmunization(child)
Kell isoimmunization of the newborn(child)
Atypical isoimmunization of newborn(child)
Duffy isoimmunisation of the newborn(child)
Kidd isoimmunization of the newborn(child)
Hemolytic disease of fetus OR newborn due to ABO immunization(child)
Late anemia due to isoimmunization(child)
Rh hemolytic disease of the newborn(child)
Microcytic anemia(parent)
Acquired hemolytic anemia(parent)
Disorder of fetus or newborn(parent)

Quick Facts

SNOMED CT
387705004
UMLS CUI
C0014761
Fully Specified Name
Hemolytic disease of fetus OR newborn due to isoimmunization (disorder)
Specialists
0
Diagnostic Biomarkers
0
Clinical Trials
1
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.